Ping An Healthcare and Technology Résultats passés
Passé contrôle des critères 0/6
Ping An Healthcare and Technology a connu une croissance annuelle moyenne de ses bénéfices de 15.6%, tandis que le secteur Consumer Retailing a vu ses bénéfices augmenter de en hausse à 15.8% par an. Les revenus ont augmenté de en baisse à un taux moyen de 1.4% par an.
Informations clés
15.6%
Taux de croissance des bénéfices
17.1%
Taux de croissance du BPA
| Consumer Retailing Croissance de l'industrie | 28.3% |
| Taux de croissance des recettes | -1.4% |
| Rendement des fonds propres | -0.2% |
| Marge nette | -0.5% |
| Dernière mise à jour des bénéfices | 30 Jun 2024 |
Mises à jour récentes des performances passées
Recent updates
Ping An Healthcare and Technology Company Limited (HKG:1833) Stock Rockets 28% As Investors Are Less Pessimistic Than Expected
Nov 17
Ping An Healthcare and Technology Company Limited (HKG:1833) Stock Rockets 30% As Investors Are Less Pessimistic Than Expected
Sep 27Ping An Healthcare and Technology Company Limited (HKG:1833) Shares Could Be 49% Below Their Intrinsic Value Estimate
Sep 20Ping An Healthcare and Technology Company Limited's (HKG:1833) Share Price Not Quite Adding Up
Jul 17Revenues Not Telling The Story For Ping An Healthcare and Technology Company Limited (HKG:1833)
Apr 17Ping An Healthcare and Technology (HKG:1833) Is In A Strong Position To Grow Its Business
Mar 20Calculating The Fair Value Of Ping An Healthcare and Technology Company Limited (HKG:1833)
Jan 12Getting In Cheap On Ping An Healthcare and Technology Company Limited (HKG:1833) Is Unlikely
Dec 22We're Hopeful That Ping An Healthcare and Technology (HKG:1833) Will Use Its Cash Wisely
Sep 27A Look At The Intrinsic Value Of Ping An Healthcare and Technology Company Limited (HKG:1833)
Sep 10When Should You Buy Ping An Healthcare and Technology Company Limited (HKG:1833)?
Aug 02Here's Why We're Not Too Worried About Ping An Healthcare and Technology's (HKG:1833) Cash Burn Situation
Jun 26Ping An Healthcare and Technology Company Limited's (HKG:1833) Share Price Could Signal Some Risk
Jun 07Is There An Opportunity With Ping An Healthcare and Technology Company Limited's (HKG:1833) 46% Undervaluation?
Apr 04Should You Think About Buying Ping An Healthcare and Technology Company Limited (HKG:1833) Now?
Feb 16We Think Ping An Healthcare and Technology (HKG:1833) Can Afford To Drive Business Growth
Jan 23A Look At The Fair Value Of Ping An Healthcare and Technology Company Limited (HKG:1833)
Jan 02Companies Like Ping An Healthcare and Technology (HKG:1833) Are In A Position To Invest In Growth
Oct 11Estimating The Fair Value Of Ping An Healthcare and Technology Company Limited (HKG:1833)
Sep 14Companies Like Ping An Healthcare and Technology (HKG:1833) Are In A Position To Invest In Growth
Jun 22We're Hopeful That Ping An Healthcare and Technology (HKG:1833) Will Use Its Cash Wisely
Mar 01We're Not Very Worried About Ping An Healthcare and Technology's (HKG:1833) Cash Burn Rate
Nov 13Are Ping An Healthcare and Technology Company Limited (HKG:1833) Investors Paying Above The Intrinsic Value?
Oct 18Companies Like Ping An Healthcare and Technology (HKG:1833) Are In A Position To Invest In Growth
Aug 05Are Ping An Healthcare and Technology Company Limited (HKG:1833) Investors Paying Above The Intrinsic Value?
Jul 10We Think Ping An Healthcare and Technology (HKG:1833) Can Afford To Drive Business Growth
Apr 04If You Had Bought Ping An Healthcare and Technology (HKG:1833) Shares A Year Ago You'd Have Earned 47% Returns
Feb 28Are Institutions Heavily Invested In Ping An Healthcare and Technology Company Limited's (HKG:1833) Shares?
Jan 24
We Think Ping An Healthcare and Technology (HKG:1833) Can Easily Afford To Drive Business Growth
Dec 29Does This Valuation Of Ping An Healthcare and Technology Company Limited (HKG:1833) Imply Investors Are Overpaying?
Dec 03Ventilation des recettes et des dépenses
Comment Ping An Healthcare and Technology gagne et dépense de l'argent. Sur la base des derniers bénéfices déclarés, sur une base LTM.
Historique des gains et des recettes
| Date | Recettes | Les revenus | Dépenses G+A | Dépenses de R&D |
|---|---|---|---|---|
| 30 Jun 24 | 4,545 | -21 | 1,871 | 0 |
| 31 Mar 24 | 4,609 | -172 | 2,094 | 0 |
| 31 Dec 23 | 4,674 | -323 | 2,317 | 0 |
| 30 Sep 23 | 5,135 | -370 | 2,480 | 0 |
| 30 Jun 23 | 5,596 | -418 | 2,643 | 0 |
| 31 Mar 23 | 5,901 | -527 | 2,756 | 0 |
| 31 Dec 22 | 6,205 | -636 | 2,869 | 0 |
| 30 Sep 22 | 6,276 | -879 | 2,950 | 0 |
| 30 Jun 22 | 6,347 | -1,121 | 3,032 | 0 |
| 31 Mar 22 | 6,841 | -1,330 | 3,318 | 0 |
| 31 Dec 21 | 7,334 | -1,538 | 3,603 | 0 |
| 30 Sep 21 | 7,636 | -1,576 | 3,524 | 0 |
| 30 Jun 21 | 7,938 | -1,614 | 3,445 | 0 |
| 31 Mar 21 | 7,402 | -1,281 | 3,024 | 0 |
| 31 Dec 20 | 6,866 | -948 | 2,604 | 0 |
| 30 Sep 20 | 6,203 | -812 | 2,564 | 0 |
| 30 Jun 20 | 5,539 | -675 | 2,524 | 0 |
| 31 Mar 20 | 5,302 | -704 | 2,403 | 0 |
| 31 Dec 19 | 5,065 | -734 | 2,282 | 0 |
| 30 Sep 19 | 4,777 | -737 | 2,294 | 0 |
| 30 Jun 19 | 4,488 | -740 | 2,306 | 0 |
| 31 Mar 19 | 3,913 | -826 | 2,270 | 0 |
| 31 Dec 18 | 3,338 | -912 | 2,233 | 0 |
| 30 Sep 18 | 3,082 | -1,182 | 2,129 | 0 |
| 30 Jun 18 | 2,542 | -990 | 1,684 | 0 |
| 31 Mar 18 | 2,205 | -996 | 1,542 | 0 |
| 31 Dec 17 | 1,868 | -1,002 | 1,400 | 0 |
| 30 Sep 17 | 1,319 | -641 | 1,211 | 0 |
| 31 Dec 16 | 601 | -758 | 1,241 | 0 |
| 31 Dec 15 | 279 | -324 | 423 | 0 |
Des revenus de qualité: 1833 n'est actuellement pas rentable.
Augmentation de la marge bénéficiaire: 1833 n'est actuellement pas rentable.
Analyse des flux de trésorerie disponibles par rapport aux bénéfices
Analyse de la croissance passée des bénéfices
Tendance des revenus: 1833 n'est pas rentable, mais a réduit ses pertes au cours des 5 dernières années à un taux de 15.6% par an.
Accélération de la croissance: Impossible de comparer la croissance des bénéfices de 1833 au cours de l'année écoulée à sa moyenne sur 5 ans car elle n'est actuellement pas rentable
Bénéfices par rapport au secteur d'activité: 1833 n'est pas rentable, ce qui rend difficile la comparaison de sa croissance des bénéfices de l'année écoulée avec celle du secteur Consumer Retailing ( -7.2% ).
Rendement des fonds propres
ROE élevé: 1833 a un retour sur capitaux propres négatif ( -0.22% ), car il n'est actuellement pas rentable.